The influence of 5-lipoxygenase on Alzheimer's disease-related tau pathology: In vivo and in vitro evidence

Biological Psychiatry

Volumn 74, Issue 5, 2013, Pages 321-328

  Chu, Jin ^a   Li, Jian Guo ^a   Ceballos Diaz, Carolina ^b   Golde, Todd ^b   Praticò, Domenico ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

5 Lipoxygenase; Alzheimer's disease; amyloid beta; cyclin dependent kinase 5; tau protein; transgenic mouse model

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CYCLIN DEPENDENT KINASE 5; MICROTUBULE ASSOCIATED PROTEIN 2; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPTOPHYSIN; TAU PROTEIN;

ADENO ASSOCIATED VIRUS; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MALE; METABOLISM; MOUSE; NEWBORN; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL;

EID: 84882256181     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.12.012     Document Type: Article

References (31)

1. F. Hernandez, and J. Avila Tauopathies Cell Mol Life Sci 64 2007 2219 2233
2. D.H. Geschwind Tau phosphorylation, tangles, and neurodegeneration: the chicken or the egg? Neuron 40 2003 457 460
3. K. Iqbal, F. Liu, C.X. Gong, and I. Grundke-Iqbal Tau in Alzheimer disease and related tauopathies Curr Alz Res 7 2010 656 664
4. R. Mederios, D. Baglietto-Vargas, and F. Laferla The role of tau in Alzheimer's disease and related disorders CNS Neurosci Ther 17 2011 514 524
5. K. Ishizawa, and D.W. Dickson Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration J Neuropathol Exp Neurol 60 2001 647 657
6. M. Kitazawa, S. Oddo, T.R. Yamasaki, K.N. Green, and F. Laferla Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5 mediated pathways in a transgenic model of Alzheimer's disease J Neurosci 25 2005 8843 8853
7. K. Bhaskar, M. Konerth, O. Kokiko-Cochran, A. Cardona, R. Ransohoff, and B. Lamb Regulation of tau pathology by microglial fractalkine receptor Neuron 68 2010 19 31
8. Y. Yoshima, M. Higuchi, B. Zhang, S.M. Huang, N. Iwata, and T.C. Saido Synapse loss and microglial activation precede tangle in a P301S tauopathy mouse model Neuron 53 2007 337 351
9. C. Chinnici, Y. Yao, and D. Praticò The 5-Lipoxygenase enzymatic pathways in the mouse brain: Young versus old Neurobiol Aging 28 2007 1457 1462
10. M.D. Ikonomovic, E.E. Abrahamson, T. Uz, H. Manev, and S.T. Dekosky Increased 5-lipoxygenase immunoreactivity in hippocampus of patients with Alzheimer's disease J Histochem Cytochem 56 2008 1065 1073
11. O. Firuzi, J. Zhou, C.M. Chinnici, T. Wisnieski, and D. Praticò 5-Lipoxygenase gene disruption reduces amyloid-{beta} pathology in a mouse model of Alzheimer's disease FASEB J 22 2008 1169 1178
12. J. Chu, and D. Pratico Pharmacologic blockade of 5-Lipoxygenase improves the amyloidotic phenotype of an AD transgenic mouse model: Involvement of γ-secretase Am J Pathol 178 2011 1762 1769
13. J. Chu, P.J. Giannopoulos, C. Ceballos-Diaz, T. Golde, and D. Pratico Adeno-associated virus-mediated brain delivery of 5-Lipoxygenase modulates the AD-like phenotype of APP mice Mol Neurodegen 7 2012 1
14. Y. Levites, K. Jansen, L.A. Smithson, R. Dakin, V.M. Holloway, P. Das, and T.E. Golde Intracranial adeno-associated virus mediated delivery of antipan amylodi Aβ, amyloid β40, and amyloid β42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice J Neurosci 26 2006 11923 11928
15. J. Kim, V.M. Miller, Y. Levites, K. Jansen West, G.W. Zwiziski, and B.D. Moore BRI2(ITM2b) inhibits Abeta deposition in vivo J Neurosci 28 2008 6030 6036
16. C. Andorfer, Y. Kress, M. Espinoza, R. de Silva, K.L. Tucker, and Y. Barde Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms J Neurochem 86 2003 582 590
17. Y. Joshi, J. Chu, and D. Pratico Stress hormone leads to memory deficits and altered tau phosphorylation in a mouse model of Alzheimer's disease J Alz Dis 31 2012 167 176
18. M. Iwakiri, K. Mizukami, M. Ikonomovic, M. Ishikawa, E. Abrahamson, S. Dekosky, and T. Asada An immunohistochemical study of GABA receptor gamma subunits in Alzheimer's disease hippocampus: Relationship to neurofibrillary tangle progression Neuropathology 29 2009 263 269
19. C.X. Gong, and K. Iqbal Hyperphosphorylation of microtubule-associated protein tau: A promising therapeutic target for Alzheimer disease Curr Med Chem 15 2008 2321 2328
20. A.P. Sampson Five lipoxygenase activating protein inhibitors for the treatment of inflammatory disease Curr Opin Investig Drugs 10 2009 1163 1172
21. T. Qu, R. Manev, and H. Manev 5-Lipoxygenase (5-LOX) promoter polymorphism in patients with early-onset and late-onset Alzheimer's disease J Neuropsychiatry Clin Neurosci 13 2001 304 305
22. J. Chu, P.J. Giannopoulos, C. Ceballos-Diaz, T. Golde, and D. Pratico 5-Lipoxygenase gene transfer worsens memory, amyloid and tau brain pathologies in a mouse model of Alzheimer disease Ann Neurol 72 2012 442 454
23. L. Martin, X. Latypova, and F. Terro Post-translational modifications of tau protein: Implications for Alzheimer's disease Neurochem Int 58 2011 458 471
24. C. Atzori, B. Ghetti, R. Piva, A.N. Srinivasan, P. Zolo, and M.B. Delisle Activation of JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis J Neuropathol Exp Neurol 60 2001 1190 1197
25. M.J. Savage, Y.G. Lin, J.R. Ciallela, D.G. Flood, and R.W. Scott Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition J Neurosci 22 2002 3376 3385
26. W. Sun, H.Y. Qureshi, P.W. Cafferty, K. Sobue, A. Agarwal-Mawal, K.D. Neufield, and H.K. Paudel Glycogen synthase kinase-beta is complexed with tau protein in brain microtubules J Biol Chem 277 2002 11933 11940
27. S.J. Liu, A.H. Zhang, H.L. Li, Q. Wang, H.M. Deng, and W.J. Netzer Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory J Neurochem 87 2003 1333 1344
28. S. Humbert, R. Dhavan, and L. Tsai p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton J Cell Sci 113 2000 975 983
29. M.S. Lee, and L.H. Tsai Cdk5: One of the links between senile plaques and neurofibrillary tangles? J Alz Dis 5 2003 127 137
30. Y.H. Hsiao, J.R. Kuo, S.H. Chen, and P.W. Gean Amelioration of social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit by N-acetylcysteine in a transgenic mouse model Neurobiol Dis 45 2012 1111 1120
31. M. Imbesi, I. Zavoreo, T. Uz, R.P. Sharma, N. Dimitrijevic, H. Manev, and R. Manev 5-Lipoxygenase inhibitor MK-886 increases GluR1 phosphorylation in neuronal cultures in vitro and in the mouse cortex in vivo Brain Res 1147 2007 148 153